What is it about?

The aim of the study was to evaluate the immunomodulatory potential of Biofield Energy Healing (The Trivedi Effect®) Treatment on the new proprietary herbomineral formulation in male Sprague Dawley rats.

Featured Image

Why is it important?

In conclusion, the data obtained from the present study revealed that the Biofield Energy Treated (The Trivedi Effect®) ashwagandha based herbomineral formulation possesses significant immunomodulatory activity compared with the untreated test formulation. Humoral immune response results suggest that the primary and secondary antibody titre values were significantly increased by 105.88% and 260% (p≤0.01), respectively in the Biofield Energy Treated test formulation (G4) group compared with the disease control (G2) group. However, untreated test formulation (G5) showed 64% increase in the secondary antibody titre and decrease in primary antibody titre compared with the G2 group. Delayed-type hypersensitivity (DTH) response in rats showed significant increase in the paw thickness by 32.43% and 53.33% (p≤0.05) at 24 and 48 hours, respectively in the G4 group compared with the disease control (G2) group. However, the percentage increase in the DTH response was higher in Biofield Energy Treated test formulation compared with the untreated test formulation (13.33%). Hematological study showed an increase in the RBC count, while the platelet count was significantly increased by 27.78% in the Biofield Energy Treated test formulation (G4) group compared with the disease control group (G2). Biochemical analysis showed significant decrease in the serum uric acid level by 36.66%, while the levels of magnesium, calcium, phosphorus, and potassium ions were increase in the Biofield Energy Treated test formulation (G4) group compared with the disease control group. In addition, the animal weight parameters such as body weight, relative organ weight, water intake, and feed intake were significantly correlated with the histopathological findings, which suggest no significant change in the Biofield Energy Treated test formulation group (G4). It mentioned that the test formulation was safe, nontoxic, and did not have any injurious effect. Therefore, the current findings concluded that The Trivedi Effect®-Biofield Energy Healing administered remotely by the twenty Biofield Energy Healers enhanced the herbomineral test formulation’s anti-inflammatory and immunomodulatory properties without any side effect, which can be used as a herbomineral product to improve the overall health. Thus, the Biofield Energy Treated test formulation may act as an effective anti-inflammatory and immunomodulatory product, and it can be used as a Complementary and Alternative Medicine (CAM) with a safe therapeutic index for various autoimmune disorders such as Lupus, Systemic Lupus Erythematosus, Fibromyalgia, Addison Disease, Hashimoto Thyroiditis, Celiac Disease (gluten-sensitive enteropathy), Multiple Sclerosis, Dermatomyositis, Graves’ Disease, Myasthenia Gravis, Pernicious Anemia, Aplastic Anemia, Scleroderma, Psoriasis, Rheumatoid Arthritis, Reactive Arthritis, Type 1 Diabetes, Sjogren Syndrome, Crohn’s Disease, Vasculitis, Vitiligo, Chronic Fatigue Syndrome and Alopecia Areata, as well as inflammatory disorders such as Irritable Bowel Syndrome (IBS), Asthma, Ulcerative Colitis, Alzheimer’s Disease, Parkinson’s Disease, Atherosclerosis, Dermatitis, Hepatitis, and Diverticulitis. Further, the Biofield Energy Healing Treated test formulation can also be used in the prevention of immune-mediated tissue damage in cases of organ transplants (for example heart transplants, kidney transplants and liver transplants), for anti-aging, stress prevention and management, and in the improvement of overall health and quality of life.

Read the Original

This page is a summary of: Immunological Effects of Biofield Energy Healing (The Trivedi Effect<sup>®</sup>) Based Novel Herbomineral Formulation After Oral Administration in Male <i>Sprague Dawley</i> Rats, Biomedical Sciences, January 2017, Science Publishing Group,
DOI: 10.11648/j.bs.20170306.13.
You can read the full text:

Read

Resources

Contributors

The following have contributed to this page